Raelipskie Partnership Repligen Corp Transaction History
Raelipskie Partnership
- $205 Billion
- Q3 2024
A detailed history of Raelipskie Partnership transactions in Repligen Corp stock. As of the latest transaction made, Raelipskie Partnership holds 25 shares of RGEN stock, worth $3,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$3,611
Previous $3.15 Million
18.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$923 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$729 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$235 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$205 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.02B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....